文献速递主动脉疾病外周动脉疾病颈动脉与弓上血管

绝经后女性心血管疾病筛查的有效性:一项基于人群的前瞻性平行队列研究

Effectiveness of Screening Postmenopausal Women for Cardiovascular Diseases: A Population Based, Prospective Parallel Cohort Study.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-04-04

这项基于人群的前瞻性平行队列研究纳入丹麦中日德兰地区1936-1951年出生的女性,邀请维堡市1936、1941、1946、1951年出生者(n=1984)参加多维度心血管疾病筛查,1474人(74.3%)参加,对照组为同一地区未受邀女性。中位随访3.3年(IQR 2.9-3.9)显示,受邀组与对照组在全因死亡、心肌梗死、缺血性心脏病、外周动脉疾病和缺血性卒中的调整HR均无显著差异。

要点

  • 多维度心血管筛查未降低绝经后女性短期全因死亡或心血管住院风险。
  • 受邀组全因死亡调整HR 0.89(95%CI 0.71-1.12),未达统计学显著。
  • 合并AAA、PAD和/或颈动脉斑块女性中45%拒绝抗血小板、35%拒绝降胆固醇治疗。

核心结论

  • 向绝经后女性普通人群提供多维度筛查在短期随访内对全因死亡或心肌梗死、缺血性心脏病、外周动脉疾病和卒中住院均无影响。

研究设计与样本

  • 基于人群的前瞻性平行队列研究,从丹麦民事登记系统识别中日德兰地区1936-1951年出生的107,491名女性,邀请维堡市1936、1941、1946、1951年出生者(n=1984)参加筛查,1474人(74.3%)参加,对照组为同一地区未受邀女性。

主要发现

  • 中位随访3.3年(IQR 2.9-3.9),受邀组 vs 对照组调整HR:全因死亡0.89(95%CI 0.71-1.12),心肌梗死1.26(95%CI 0.52-3.07),缺血性心脏病0.72(95%CI 0.49-1.05),外周动脉疾病1.07(95%CI 0.49-2.31),缺血性卒中1.20(95%CI 0.78-1.85)。
  • 合并AAA、PAD和/或颈动脉斑块的女性中,45%拒绝抗血小板预防治疗,35%拒绝降胆固醇药物治疗。

局限性

  • 随访时间短(中位3.3年,IQR 2.9-3.9)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the effectiveness of systematic screening for multifaceted cardiovascular disease (CVD) in postmenopausal women on all cause mortality and, secondarily, on CVD morbidity. Effectiveness was also evaluated across age strata. METHODS: This was a population based, prospective, parallel cohort study. In total, 107,491 women born in 1936-1951 living in the Central Denmark region were identified in the Danish Civil Registration System. From this population, all women born in 1936, 1941, 1946, and 1951 (n = 1984) living in the Viborg municipality were invited to attend screening. Of those invited to the screening, 1474 (74.3%) attended. The control group included all women from the general population born in 1936-1951 and living in the Central Denmark Region, excluding those invited for the screening. Information on medication and comorbidities prior to inclusion and study outcomes were retrieved from national registries for both groups. The screening included examination for abdominal aortic aneurysm (AAA), peripheral arterial disease (PAD), carotid plaque (CP), potential hypertension (HT), atrial fibrillation (AF), diabetes mellitus (DM), and dyslipidaemia. The adjusted Cox proportional hazards model with the intention to screen principle was used to assess effectiveness for the total population and across age groups. RESULTS: During follow up (median 3.3 years, IQR 2.9-3.9), the adjusted hazard ratios (HRs) for invited versus controls were the following: all cause mortality, 0.89 (95% CI 0.71-1.12); myocardial infarction (MI), 1.26 (95% CI 0.52-3.07); ischaemic heart disease (IHD), 0.72 (95% CI 0.49-1.05); PAD, 1.07 (95% CI 0.49-2.31); and ischaemic stroke, 1.20 (95% CI 0.78-1.85). A substantial number of women with AAA, PAD, and/or CP declined prophylactic therapy: 45% for antiplatelet and 35% for cholesterol lowering agents. CONCLUSIONS: This multifaceted screening offer to a general population sample of postmenopausal women had no effects on all cause mortality or hospital admission for MI, IHD, PAD, and stroke within a short-term follow up period.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Dahl M, Søgaard R, Frost L, et al. Effectiveness of Screening Postmenopausal Women for Cardiovascular Diseases: A Population Based, Prospective Parallel Cohort Study. Eur J Vasc Endovasc Surg. 2018. PMID: 29625727. doi:10.1016/j.ejvs.2018.02.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。